Close Concerns
Close Concerns provides consulting services on diabetes and obesity to a wide range of established and start-up corporate clients, including pharmaceutical, medical device, and biotechnology companies. Close Concerns also publishes Closer Look, a daily newsletter focused on clinical and commercial developments in the field, and produces special reports on products and trends influencing diabetes and obesity. They attend 40+ medical conferences and meetings per year globally that focus on diabetes and obesity. Close Concerns publishes diaTribe, an online newsletter for patients with diabetes with 15,000 subscribers. Each quarter, Close Concerns surveys thousands of patients in order to stay on top of patient preferences. Close Concerns also has strong relationships with many of the leading researchers and clinicians in diabetes and obesity. www.closeconcerns.com
Council Members
There are 2 experts at Close Concerns
-
Kelly Close
President
-
Mark Yarchoan
Consultant
Top Study Groups
Study Groups are clusters of experts with similar progessional backgrounds, indsutry expertise, experience level, job function, geography, and other characteristics. These are the top Study Groups members of Close Concerns belong to.
| Study Group Name | No. Members |
|---|---|
| Experts in the Leisure & Lodging Council | 4887 |
| Experts in the Automotive Council | 3422 |
| Physicians who Treat Diabetes (US) | 466 |
| Medical Geneticists (US) | 85 |
| DexCom's Continuous Glucose Monitoring System Experts | 27 |
News Analyses
GLG News analyses are expert commentaries on industry news and events. Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
-
Novo Nordisk's Liraglutide Wins in Obesity Too
October 29, 2009
Kelly Close, President, Close Concerns
-
Major Turnaround- NEJM VADT Correction Shows MVC Benefits of Intensive Control
October 19, 2009
Kelly Close, President, Close Concerns
-
LEAD-6 Extension Trial Results Announced-- Look Positive for Novo Nordisk
October 17, 2009
Kelly Close, President, Close Concerns
-
October 5, 2009
Kelly Close, President, Close Concerns
-
Afresa suppresses gluconeogenesis more readily than Humalog or Exubera
October 2, 2009
Kelly Close, President, Close Concerns